EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro , ex vivo and in vivo systems

Stephanie Supparitsch, Markus Zeitlinger

Journal of Antimicrobial Chemotherapy · 04.03.2026 · 81 (4)

DOI: 10.1093/jac/dkag091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 06.03.2026. Verfasst von Stephanie Supparitsch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm-associated infections represent a major therapeutic challenge due to reduced antimicrobial susceptibility and the limited predictive value of conventional pharmacokinetic/pharmacodynamic (PK/PD) indices with clinical outcome. A wide spectrum of experimental models has been developed to study biofilms, ranging from simple in vitro assays to ex vivo tissue-derived systems and in vivo infection models. Each category provides distinct advantages: in vitro platforms enable high-throughput compound screening and measurement of biofilm-specific indices such as MBIC and MBEC; ex vivo models preserve host tissue architecture and allow investigation of topical therapies and therapeutic windows; and in vivo systems are indispensable for analysing host–pathogen interactions and systemic PK/PD relationships. No single model is sufficient to replicate clinical biofilm complexity, but combined use and progressive standardization can improve translational value. This review provides a structured overview of available models, their PK/PD readouts and their strengths and limitations, aiming to guide model selection in preclinical biofilm research and antimicrobial development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsAnti-Bacterial AgentsHumansAnimalsMicrobial Sensitivity TestsDrug Evaluation, PreclinicalModels, BiologicalBacterial Infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria.

Zitieren

APA

Supparitsch, S., & Zeitlinger, M. (2026). Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro , ex vivo and in vivo systems. Journal of Antimicrobial Chemotherapy, 81(4). https://doi.org/10.1093/jac/dkag091

Vancouver

Supparitsch S, Zeitlinger M. Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro , ex vivo and in vivo systems. Journal of Antimicrobial Chemotherapy. 2026;81(4). doi:10.1093/jac/dkag091

BibTeX
@article{Supparitsch2026,
  author = {Supparitsch, Stephanie and Zeitlinger, Markus},
  title = {Experimental biofilm models for pharmacokinetic and pharmacodynamic investigations: bridging in vitro , ex vivo and in vivo systems},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {4},
  doi = {10.1093/jac/dkag091}
}
Kostenlos starten →